Using an isoelectric-focusing (IEF) method developed to quantitiate MM isoenzyme-creatine kinase (CK) sub-band activity, we identified a reproducible time-varying pattern of these sub-bands in the serum of eight patients with acute myocardial infarction (MI). Our observations are consistent with the view that MM3-CK (the M2-CK dimer, the pure gene product) is converted intravascularly to MM2-CK, and then to MM1-CK (the M1-CK dimer, the pure postsynthetic sub-band). The MM3-CK reaches a peak first, 16 hours after infarction, followed by MM2-CK, and then by MM1-CK. The MM3-CK is the dominant sub-band in normal myocardium; there is much less MM2-CK and virtually no MM1-CK. The MM3-CK sub-band peak may indicate the time at which enzyme ceases to be released from the injured myocardium. The ratio MM3-CK:MM1-CK rises within 6 hours after onset of chest pain from a baseline of 0.38 and peaks 10 hours after MI. The peak ratio was between 1.1 and 4.2, and the valu'e correlated with the time when total CK activity peaked after MI. The 10-fold change in the MM3:MM1 ratio after MI, as well as the early period at which this ratio peaks (10 hours), makes this an earlier and more sensitive indicator of enzyme release. tiorns). The precise nature of the MM-CK sub-band
THE MM, MB, and BB isoenzymes are not the only forms of creatine kinase (CK) that can appear in serum. Wevers et al. ' were the first to demonstrate that three, or perhaps four, isoforms of the. MM-CK isoenzyme and two MB isoforms can be identified by prolonging the usual time for a-standard electrophoresis or by isoelectric focusing (IEF) . To account for three MM-CK sub-bands, Wevers et al. 2 proposed and reported supportive protein hybridization experiments, the existence of two M-chain monomers, Ml and M2. They proposed that the M I monomer was formed from the M2 monomer by a low-molecular-weight, heatlabile, dialyzable converting factor normally present in serum. 3 The M2 CK monomer was considered the native or gene product. Chapelle and Heusghem4 and Falter et al. 5 confirmed these findings and demonstrated that after acute muscle injury, such as trauma or acute myocardial infarction (MI), serum levels of MM-CK sub-bands rise and fall, but each one reaches a peak sequentially, as one would expect of a process involving sequential transformation. In a separate stiudy of experimental MI in animals, we showed that this transformation occurs almost entirely within the vascular compartment and not at the site of damage or in cardiac lymph (Abendschein DR, Morelli RL, Carlson CJ, Emilson B, Rapaport E: unpublished observa-conversion is not known. We therefore studied the changes in MM-CK sub-band activity after acute MI.
Methods
Eight male patients, ages 45-70 years, who were admitted to the Coronary Care Unit of the San Francisco General Hospital Medical Center because of MI were studied. Informed, written consent was obtained according to the guidelines approved by the Committee on Human Research at the University of California, San Francisco. No patient had any other disease known to raise total CK activity and no patient had received any intramuscular or subcutaneous injections.
The patients were diagnosed as having had an acute MI when the following criteria were met: clinical history of prolonged chest pain suggestive of acute MI, acute injury pattern with localized ST-segment elevation on a standard 12-lead ECG with subsequent evolution and Q-wave formation and characteristic rise and fall in total serum CK activity with associated significant MB-CK activity (D 3% of total serum CK activity). Only patients who sought medical attention early and had the first sei-um sample drawn within 4 hours after the onset of chest pain, thought to represent the onset of myocardial infarction, participated in the study. Serum samples for CK analysis were obtained immediately after admission to the hospital, every 2-4 hours for the first 24 hours and every 4-8 hours for the following 72 hours or until the total CK level returned to normal ( 50 IU/1). All samples were obtained from an indwelling intravenous catheter to minimize discomfort to the patient. Enough blood was drawn to clear the line and was discarded. Three milliliters of blood were collected and allowed to clot at room temperature; the serum was separated by desk-top centrifugation for 5 minutes at high speed. Analysis of total CK activity, CK isoenzyme activity, and MM-CK sub-band activity was carried out immediately after collection of serum whenever possible. When not possible, the serum was stored at -4°C and was analyzed within 48 hours.
Enzyme Assays
Total serum CK activity was measured by the coupled enzyme assay of Rosalki6 and expressed in IU/l at 250C.
The MM, MB, and BB isoenzyme activities relative to total CK activity were measured by electrophoretic separation on agarose gels and fluorescent scanning according to the method of Elevitch;7 the results were expressed as percent of MM, MB, and BB of the total scanned area. The MM3, MM2, and MM 1-CK sub-band activities relative to total MM-CK activity were determined using an IEF method. We used neutralized, isoagarose 1-mm-thin gel (Isogel, FMC Corporation) on a flatbed electrophoresis system (Pharmacia Fine Chemicals) and carrier ampholytes with a pH range of 5-8 (LKB). The gel-ampholyte film was prefocused with 100 V at 7°C for 10 minutes. A 1-5-gg sample was applied with the aid of a mask, and the film was focused at 7.5 W constant power for 15 minutes. We used NaOH for the cathode and either glutamic acid, aspartic acid, or HEPES as the anode. We used a glucose-6-phosphate dehydrogenase CK coupled enzyme reagent (A-gent CPK Test, Abbott Laboratories) to identify the MM-CK sub-bands and measured the relative activity of each sub-band by fluorometric scanning (Turner Instruments) for nicotinamide adenine dinucleotide phosphate production.
The relationship between fluorescence intensity and enzyme activity for each sub-band on the IEF film was assessed using serial dilutions of a sample containing known total serum CK activity. The reproducibility of the method was established by analyzing 15 aliquots each of several samples on different days and on different IEF plates. Eight volunteers without evidence of diseases known to elevate CK activity were similarly studied to establish normal serum activity ranges for the MM-CK sub-bands.
Sera from nine patients with diseases known to elevate total CK activity were studied: seven patients with different myopathies and two patients immediately after multiple trauma.
Normal Tissue
Human myocardium was obtained as part of a routine biopsy from the left ventricular septum of two patients undergoing surgery for correction of tetralogy of Fallot. Normal human skeletal muscle was obtained by biopsy of the rectus abdominus muscle from two patients undergoing abdominal surgery.
The tissue samples (500 mg) were immediately frozen and stored at -20°C until they could be analyzed. When analyzed, the samples were thawed and homogenized by mortar and pestle in 5-10 ml of trisphosphate buffer, pH 8.6, at 4°C. After two ultracentrifugations, the supematant was diluted appropriately to yield a sample activity of about 100,000 IU/l. For CK determination and MM-CK sub-band analysis, the sample was again diluted to give a final activity of 50-250 IU/l. The total protein present in each sample was measured by the method of Lowry et al.8
Results
In all cases the first serum sample had normal total serum CK activity ( 50 IU/l) and MB-CK activity was not detected. Total CK activity peaked at 23 + 4 hours after MI (mean ± SD). Peak total CK activity was 54-1350 IU/l. Figure 
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serum pattern from a patient after acute MI. Electrophoresis was carried out for 20 minutes at pH 8.6, the method normally used to detect and quantitate MB-CK activity for routine diagnostic purposes. Figure lB shows the same serum electrophoresed for 90 minutes at pH 8.6. After this extended electrophoresis, three sub-bands of MM-CK could be identified: MM1, MM2, and MM3, respectively, corresponding to their mobility from the cathode. Figure IC shows the results using the IEF method. Five sub-bands could be identified: X, MM1, MM2, and MM3 relative to their mobility from the cathode. This nomenclature is opposite to that adopted by Wevers et al., I who referenced protein mobility to the anode, except for X, which represents the same entity. The fifth sub-band, Y, migrated ahead of X and typically had low activity. The sub-bands MM3, MM2, MM1, X and Y were proved to have only CK activity by incubating the electrophoretic gels of identical samples, one with and one without creatine phosphate substrate. There was no residual fluorescence when the substrate-poor solution was used. The IEF on polyacrylamide gels, instead of isoagarose, revealed the same MM-CK subbands. These sub-bands were proved to be MM-CK isoenzymes by using antiMM antibody (Upjohn). There were no bands of CK activity when the gel was incubated with the anti-MM antibody after focusing. The same gels incubated with anti-BB antibody failed to change the relative activities of the MM-CK subbands.
Although the activity of the MM-CK isoenzymes is pH-dependent and most active in the rate of 7.0-7.4, flattening the pH gradient with 0.2 M phosphate buffer, pH 7.0, before application of the coupled enzyme reagents had no effect on the relationships among scanned areas of each MM-CK sub-band; nor was the relative MM-CK activity of each sub-band affected by incubating serum with a reducing agent, 0.1 M mercaptoethanol, or an oxidizing agent, 0.1 M potassium iodide. Total CK activity was not affected by the 2.5% carrier ampholyte solution.
Serial dilutions of a sample with known total CK activity did not affect the relationships among the MM-CK sub-bands. The coefficient of variation of each of the scanned areas corresponding to each MM-CK subband after IEF was 2.4% for 12 scans of three samples diluted over a 10-fold range. There was a linear relationship between incubation time and the fluorescent intensity of each sub-band when samples were incubated with substrate for 10, 15, 20, 25, and 30 minutes (r = 0.98, SEE = 0.4%).
Repeated measurements of sub-band activity on aliquots of two preserved samples had a maximum coefficient of variation of 18.4% for each MM-CK sub-band with total CK activities of 85 and 685 IU/l measured over a period of 11 and 62 days, respectively. The assay was sensitive and would separate MM-CK subbands on samples with a total CK activity 25 IU/1. However, MM-CK sub-bands were most clearly separated when sample total CK activity exceeded 50 IU/1. Table 1 shows the isoelectric points (pI) and MM- CK sub-band activity relative to total MM-CK found in serum from normal volunteers and in normal myocardial and striated muscle. Whereas the dominant MM-CK sub-band in serum is the MM1, the pure postsynthetic sub-band, the dominant band in myocardial and striated tissue is MM3, the pure gene product. The X and Y MM-CK sub-bands were not consistently found in normal serum. Only X MM-CK, and not Y, is found in normal myocardium. Figure 2A shows the average time course of MM-CK, MM-CK subtypes, and MB-CK activity in all patients after MI. Figure 2B shows all MM-CK subbands activity changes in these patients. In all patients, MM3, MM2, and MM1-CK began to increase within 6 hours after MI and peak sequentially (table 2): MM3 reached a peak first, followed by MM2 and then MM 1. The X sub-band paralleled the MM I -CK. When the Y sub-band was detectable (in five of the eight patients), its activity was much lower compared with the other sub-bands. Like the X sub-band, Y activity paralleled MM1-CK, but its first appearance was considerably delayed. During the 4 hours immediately after the onset of MI, the serum resembled the normal sub-band pattern and returned to a nearly normal pattern 30 hours after MI. Total CK and MB-CK activity reached a peak 24 hours after the onset of chest pain, whereas MM3 activity peaked 8 hours earlier. Although the relationships among sub-band activities changed more toward the myocardial pattern soon after myocardial necrosis began, MM3 activity never reached the 63% found in normal muscle.
The rate of MM3-CK release from the myocardium, F(t)MM3, as a function of time after the onset of chest pain, calculated according to the method of Shell,9 closely paralleled the time course of the MM3-CK activity curve (table 2). The integral over time of F(t)MM3 represents the total MM3-CK released from the myocardium. Figure 3 shows a plot of the mean MM3-CK:MM1-CK ratio (the pure gene product and the pure postsynthetic product, respectively) as a function of the time after onset of chest pain for the eight patients. The ratio in these patients within the first 4 hours after infarction (0.32) did not differ from that in the normal volunteers with normal total CK levels (0.38) ( and MB-CK began to rise in the serum. Whereas total CK and MM-CK peaked 24 hours after MI and MM3 16 hours, the MM3:MM1 ratio peak averaged 10.6 hours after MI, even earlier (3.4 hours, p < 0.01) than time to peak of MM3-CK rate of release function. Also, there was an inverse linear relationship between peak MM3:MMl and the time to peak total MM-CK activity (r = -0.713). The very early peak of the MM3:MMl ratio preceded total CK and MB-CK activity by 14 hours, peak MM3 by 6 hours (p < 0.02), and peak rate of MM3-CK release by 4 hours (p < 0.01). There was no correlation between this peak ratio and the area under the total CK or MM1 activity curves. However, there was a significant (p < 0.001) linear correlation between the MM3:MMI ratio and the rate of release of MM3-CK from the myocardium (r = 0.950). In one patient, MM3 release preceded the rise in MB-CK activity. The total CK activity was 54 IU/l, only slightly above normal, but the MM3:MMI ratio was > 1.0 and, in fact, reached a peak of 2.3 8 hours after onset of chest pain. Table 3 lists the average rates of change for the early and late log-linear portions of each sub-band curve. The MM3 sub-band increases and decreases faster than MM2, and MM2 is faster than MMI. The terminal decay rate of total CK and MM-CK activity was most nearly equivalent to the MM 1 sub-band. The X and Y sub-band rates of change were more similar to MM1 and total CK than to the other sub-bands or MM-CK. The ratio between MM3 and MM1 serum activity did not return to the control value even after 100 hours after the onset of chest pain; MMl was still elevated when MM3 had returned to normal levels. Table 3 also shows the area under the activity-time curve for each MM-CK sub-band. The area under the MM2-CK curve was slightly more than twice that of the MM3-CK time activity curve. The MMI -CK curve was about three times the MM3-CK curve. The correlation between the various curve areas was 0.9 for MM3 vs MM2 and 0.6 for MM3 vs MMI. Table 4 lists the MM-CK sub-band activities in two patients after trauma and in several patients with diseases that elevate total CK activity. When total CK and MM-CK activities were elevated acutely, whether MB-CK activity was detected or not, the predominant MM-CK sub-band shifted from MM 1 -CK to MM3-CK. We observed this pattern in the eight patients after MI. In the seven patients with presumably chronic disease, the relationships among sub-bands were variable.
Discussion
In all patients, during the first 4 hours after the onset of chest pain, the serum MM-CK sub-band activity resembled the pattern seen in normal volunteers, with the MM1-CK sub-band dominant. After the first 6 hours, MM3 became dominant, and the normal pattern returned to nearly baseline levels 24 hours after onset of MI. The MM3-CK reached peak serum activity 16 hours after the onset of chest pain, 8 hours sooner than peak total CK-MM and MB-CK serum activities. Because of sub-band peak activities and the area under the total CK activity-time curves correlate highly with the total CK activity values and because peak total CK activity correlated with morbidity and mortality,'0 peak MM3 serum activity probably provides the same prognostic information, but 8 hours sooner.
Although the meaning of the MM3:MM1 ratio is uncertain, dependent on the mechanism of sub-band transformation, the peak ratio occurred even earlier than peak MM3-CK activity or peak MM3-CK release, 10 hours after chest pain. The linear correlation between the MM3:MM1 ratio and the rate of MM3-CK release indicates that the ratio is an index of enzyme release from the damaged myocardium. The peak ratio did not correlate with peak values or curve areas. It did, however, correlate inversely with time to peak such that the higher the peak ratio, the sooner the peak MM3 activity occurred. The peak value for the MM3:MM1 ratio was 1. 1-4.2 for the patients. Thus, a MM3:MM1 ratio exceeding 1.0 indicates continued rapid release of MM3 from the injured cell and the actual value implies the rate at which enzyme is being released.
The ratio may show dramatic changes soon after onset of myocardial infarction, before MB-CK activity appears in serum. In the one patient whose peak total CK did not rise much above the normal value of 50 IU/ 1, the MM3:MM1 ratio showed a dramatic increase 8 hours after onset of chest pain, rising from a baseline value of 0.25 to 2.3, a ninefold increase, in contrast to the threefold increase in the total CK activity. Thus, the MM3:MM 1 ratio may be a more sensitive indicator of enzyme release.
There was no difference between the times to peak of the MM3-CK rate of release and the MM3-CK activity curves. Thus, the peak of the MM3-CK activity curve indicates the time when the rate of sub-band disappearance exceeds the rate of appearance of the untransformed MM-CK into the blood, or the end of the rapid-release phase. Likewise, there was no difference in the times to return to baseline of the MM3-CK rate of release and the MM3-CK activity curves. However the MM3:MM1 ratio returned to its previously normal value 27 hours after infarction and continued to fall below baseline levels even 100 hours after the MI began, long after MM3 activity had returned to normal levels. This indicates continued transformation of MM3 to MMl in the face of further, albeit diminished, MM3-CK release. Consequently, the relationships among the MM-CK sub-bands may reveal the pattern of enzyme release from injured myocardium.
The MM3-CK activity curve had the fastest rate of rise and fall, followed by MM2 and then by MM1. The time to peak activity for each of the sub-bands MM3, MM2 and MMl-CK differed significantly, as did their rates of appearance and terminal decay from the serum. The sub-bands seemed to behave differently, which is consistent with the interpretation of Wevers et al. I-3 of sub-band conversion from one to the other and with our animal studies (unpublished observations) that indicated that conversion occurred within the serum. Thus, serum changes in MM-CK sub-bands are explained as follows: MM3, the predominant sub-band in normal myocardium, is released into serum after infarction, either directly or by way of cardiac lymph, and then each monomer is converted from the M2 to the M 1 form in serum, which accounts for the sequen-tial occurrence of an MM2 and then an MM1 activity peak as we observed in our patients. Thus, just as total CK activity is not due to a single protein, for it is composed of the three isoenzymes MM, MB and BB, the same is true for MM-CK, because it is composed of more than one protein. The upstroke of the total CK activity appearance curve is predominantly due to the MM3-CK sub-band, whereas the terminal decay portion of the curve is mostly due to the MM 1-CK subband. The peak total CK activity is a composite of all the MM-CK sub-bands, MM3, MM2, and MM1, as well as MB-CK activity. Thus, the total CK activitytime curve after myocardial infarction is a composite of protein forms. By considering these previously unrecognized MM-CK isoenzymes and the undefined variables that might affect the transformation process, we may be able to improve the CK method of estimating and predicting myocardial infarct size.
Wevers et al.2 described another sub-band of MM-CK activity in myocardial tissue and called it X. This sub-band was verified by Chapelle and Heusghem,4 but was considered an artifact of prolonged staining for CK. We showed that the X sub-band is not an artifact but a true sub-band of MM-CK activity, as Yasmineh et al."' also contend. There appears to be yet another sub-band of MM-CK activity, which we called Y, that migrates ahead of X on IEF, is of low activity, and is not found consistently in all patients after MI. This inconsistency may result from incomplete physical separation of the sub-band or from the relative insensitivity of the method when it is used to quantitate such a low activity sub-band; it may not mean necessarily true absence of the Y sub-band in some patients. The nature of both the Y and X sub-bands is not known; we showed that they have CK activity and are not artifacts.
Neither X nor Y could be identified in the serum of normal volunteers with normal total CK activity; Y was not found in normal myocardium. Both the X and Y sub-bands rose and fell during the course of an evolving MI, but paralleled the course of the MM1-CK activity curve, the slowest of the three major sub-bands to appear and disappear from the serum.
We can only speculate on the nature of the X or Y sub-band of CK activity. Clearly, the theory of Wevers et al. I-3 cannot explain a fourth or fifth sub-band of CK 1288 CIRCULATION activity given two M monomers, unless we postulate further postsynthetic transformation of any of the subbands or individual M monomers. The Y sub-band may be a conversion product of X, although that does not explain what X might be.
Clinical Implications
There is additional information contained in the sequential changes in serum MM-CK sub-bands after myocardial infarction. The diagnostic importance of such information, however, requires further elucidation. Measurement of MM-CK sub-band activity may not increase the predictive value of enzyme tests after acute MI, but may be helpful in diagnosing acute MI earlier. First, the sequential changes in MM-CK subbands we observed after MI also occur whenever MM-CK activity is released into the serum. Second, in only one patient with low peak total CK activity did evidence of MM-CK release (an MM3:MMl ratio 1.0) develop before MB-CK activity became elevated. We would like to see this phenomenon verified in a large number of patients. The MM3:MMI ratio does provide information from a single sample on the direction of serum CK changes: If MM3:MM1 exceeds 1.0, CK activity is being released into the circulation. This may increase the sensitivity of current tests for indicating a changing CK activity, particularly when total CK activity is normal. Because there are at least three MM-CK isoenzymes that peak sequentially after MI, the relationships among the isoenzymes at any time after the onset of release would be unique and would be useful for timing the onset of enzyme release and thus the onset of infarction. Furthermore, these relationships can be used to assess the rate of enzyme release from the myocardium as well as the total time after the onset of infarction during which enzyme release takes place. The potential clinical importance of such information is self evident. However, these relationships depend on more explicit knowledge of the enzyme transformation process itself and a more direct means of estimating MM-CK sub-band activity.
